Stefano Fiorucci

About Stefano Fiorucci

Stefano Fiorucci, With an exceptional h-index of 87 and a recent h-index of 47 (since 2020), a distinguished researcher at Università degli Studi di Perugia, specializes in the field of Gastroenterology and hepatology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis

A microbial derived bile acid acts as GPBAR1 agonist and RORγt inverse agonist and reverses inflammation in inflammatory bowel disease

The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIV

Bile acids and bile acid activated receptors in the treatment of COVID-19

Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of …

Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease

Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”

Quinoline compounds as selective and/or dual modulators of bile acid receptors and leukotriene cysteinyl receptors

Stefano Fiorucci Information

University

Position

___

Citations(all)

27581

Citations(since 2020)

9210

Cited By

21815

hIndex(all)

87

hIndex(since 2020)

47

i10Index(all)

299

i10Index(since 2020)

183

Email

University Profile Page

Google Scholar

Stefano Fiorucci Skills & Research Interests

Gastroenterology and hepatology

Top articles of Stefano Fiorucci

Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis

Biochemical Pharmacology

2024/5/1

A microbial derived bile acid acts as GPBAR1 agonist and RORγt inverse agonist and reverses inflammation in inflammatory bowel disease

bioRxiv

2024

The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIV

Journal of Medical Virology

2023/1

Bile acids and bile acid activated receptors in the treatment of COVID-19

2023/12/9

Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of …

Journal of the American Heart Association

2023/12/5

Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease

Biochemical Pharmacology

2023/12/1

Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”

ACS omega

2023/11/16

Quinoline compounds as selective and/or dual modulators of bile acid receptors and leukotriene cysteinyl receptors

2023/11/9

The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer

Cellular Oncology

2023/11/9

Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders

2023/9/1

Combinatorial targeting of G‐protein‐coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug …

Hepatology

2023/7/1

Theonella: A Treasure Trove of Structurally Unique and Biologically Active Sterols

2023/5/8

Mo1239 MODULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 4 EXPRESSION BY LIF VIA STAT3 PHOSPHORILATION IN GASTRIC CANCER

Gastroenterology

2023/5/1

Sa1749 DISCOVERY OF NEW MOLECULE; AGONIST OF GPBAR1 AND INVERSE AGONIST OF RORΓT, FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

Gastroenterology

2023/5/1

Su1416 NATURAL AND SYNTHETIC BILE ACIDS FUNCTION AS LEUKEMYA INHIBITORY FACTOR RECEPTOR (LIFR) ANTAGONISTS AND REVERT PROLIFERATION AND MIGRATION IN PANCREATIC CANCER CELL LINES

Gastroenterology

2023/5/1

217 BAR502, A DUAL FXR AND GPBAR1 AGONIST, SYNERGIZED ATORVASTATIN BENEFICIAL EFFECTS ON VASCULAR INFLAMMATION IN NASH

Gastroenterology

2023/5/1

Bile Acids and SARS-CoV-2: Ursodeoxycholic Acid as a Potential Treatment of COVID-19

Recent Advances in Inflammation & Allergy Drug Discovery

2023/5/1

Stefano Fiorucci
Stefano Fiorucci

H-Index: 44

Modeling inflammatory bowel disease by intestinal organoids

2023/5/1

Expanding the Library of 1, 2, 4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists

Molecules

2023/3/21

Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma

Frontiers in Oncology

2023/3/14

See List of Professors in Stefano Fiorucci University(Università degli Studi di Perugia)

Co-Authors

academic-engine